-
1.
公开(公告)号:EP4245309A1
公开(公告)日:2023-09-20
申请号:EP21891278.0
申请日:2021-11-16
申请人: Inner Mongolia Yili Industrial Group Co., Ltd. , Inner Mongolia Dairy Tech Res Institute Co Ltd
发明人: WEISS, Gisela Adrienne , VAN LOO-BOUWMAN, Carolien Annika , SMIT, Gerrit , WANG, Wendan , SZETO, Ignatius Man-Yau , GU, Fangjie , LIU, Biao
IPC分类号: A61K35/745 , A61K31/702 , A61P31/04
摘要: The present disclosure provides a composition comprising Bifidobacterium lactis and human milk oligosaccharides (HMOs) and use thereof. The composition is capable of effectively enhancing resistance of an organism to Staphylococcus aureus infection, improving innate immunity of an organism, and/or anti-aging, and can be added to various health foods and healthcare foods.
-
公开(公告)号:EP4442265A1
公开(公告)日:2024-10-09
申请号:EP22900323.1
申请日:2022-11-22
申请人: Inner Mongolia Yili Industrial Group Co., Ltd. , Inner Mongolia Dairy Tech Res Institute Co Ltd
发明人: HUNG, Wei-Lian , SHI, Yujie , LIU, Wei-Hsien , FENG, Haotian , LIU, Biao , LI, Wei , CHEN, Qingshan , ZHOU, Mingqiao
IPC分类号: A61K35/745 , A61P19/00 , A23L33/135
CPC分类号: Y02A50/30 , A23C9/16 , A23K10/18 , A23K10/16 , A61P19/10 , A61K31/733 , A61P19/00 , A23C19/06 , A61K31/7016 , A61K31/702 , A23L33/21 , A23C9/123 , A61P19/08 , A61K35/745 , A23L2/38 , A23C19/032 , A23L33/135
摘要: Disclosed is the use of Bifidobacterium lactis BL-99 in the protection of cartilage. Provided in the present invention is the use of Bifidobacterium lactis in the preparation of a composition for protecting cartilage, wherein the Bifidobacterium lactis is Bifidobacterium lactis with the deposit number of CGMCC No. 15650. The Bifidobacterium lactis can promote the development of cartilage, increase cartilage density, protect cartilage from damage, promote cartilage repair and/or ameliorate cartilage damage, and is beneficial to cartilage health.
-
3.
公开(公告)号:EP4252538A1
公开(公告)日:2023-10-04
申请号:EP21896062.3
申请日:2021-01-27
申请人: Inner Mongolia Yili Industrial Group Co., Ltd. , Inner Mongolia Dairy Tech Res Institute Co Ltd
发明人: WANG, Wendan , SZETO, Ignatius Man-Yau , LIU, Biao
摘要: Disclosed is the use of a breast milk oligosaccharide in the preparation of a food product for improving intestinal microenvironment health. Improving intestinal microenvironment health comprises: in the intestinal system, using the breast milk oligosaccharide as prebiotics used by means of intestinal flora and producing gas, reducing pH to maintain intestinal microenvironment health, and/or reducing the production of branched-chain fatty acids such as isobutyric acid and/or isovaleric acid, and regulating the production of beneficial short-chain fatty acids such as formic acid, acetic acid, propionic acid and/or butyric acid in the intestinal system. The breast milk oligosaccharide is selected from one or more of fucosyl oligosaccharide, sialyl oligosaccharide or lactose-N-tetrasaccharide. The food product comprises an infant formula powder, a complementary food product, a nutritional supplement, and a nutritional supplement or food product for children of 3 years of age and over, teenagers and adults.
-
4.
公开(公告)号:EP4129302A1
公开(公告)日:2023-02-08
申请号:EP21780538.1
申请日:2021-04-06
申请人: Inner Mongolia Yili Industrial Group Co., Ltd. , Inner Mongolia Dairy Tech Res Institute Co Ltd
发明人: WEISS, Gisela Adrienne , VAN LOO-BOUWMAN, Carolien Annika , SMIT, Gerrit , WANG, Wendan , SZETO, Ignatius Man-Yau , GU, Fangjie , LIU, Biao
IPC分类号: A61K31/702 , A61P31/00 , A61P1/00
摘要: A use of breast milk oligosaccharides in the preparation of a nutritional composition or drug; the nutritional composition or drug is used to prevent and/or treat diseases related to Staphylococcus aureus infection in an individual, to alleviate the discomfort associated with Staphylococcus aureus infection, to improve the resistance of an individual against Staphylococcus aureus infection, or to improve the innate immunity and/or resistance of an individual to aging. The breast milk oligosaccharides are selected from: 2'-fucosyllactose, 3-fucosyllactose, lactose-N-tetraose, 6'-sialyllactose, and any combination thereof, and a combination formed by 3'-sialyllactose and one or more among 2'-fucosyllactose, 3-fucosyllactose, lactose-N-tetraose, and 6'-sialyllactose.
-
5.
公开(公告)号:EP3718415A1
公开(公告)日:2020-10-07
申请号:EP18884296.7
申请日:2018-10-11
发明人: CHANG, Pengfei , LIU, Biao , KONG, Xiaoyu
摘要: The present invention provides a composition for debittering hydrolyzed proteins and a product, preparation and use thereof. The composition comprises a short chain fatty acid, a medium chain fatty acid and a long chain fatty acid, wherein, based on total mass of the short chain fatty acid, the medium chain fatty acid and the long chain fatty acid which is 100%, the medium chain fatty acid is present in an amount of 0.2-4.7%, the long chain fatty acid is present in an amount of 95.1-99.4%, and the remaining is the short chain fatty acid. The present invention can effectively reduce the bitter taste of hydrolyzed proteins and is widely used.
-
公开(公告)号:EP4059354A1
公开(公告)日:2022-09-21
申请号:EP20887296.0
申请日:2020-11-16
发明人: SHI, Yujie , LIU, Biao
IPC分类号: A23L33/135 , A61K35/745 , A23C9/16 , C12P7/52
摘要: Provided is a synergistic combination of butyric-acid-producing prebiotics and probiotics, which is used in the fields of foods, dietary supplements and drugs. Specifically, the present invention relates to a composition containing probiotics and prebiotics, a food, dietary supplement or pharmaceutical preparation comprising the composition, and the use of the composition for alleviating and improving a disease or a discomfort, or reducing the occurrence of a disease or a discomfort, wherein the disease or discomfort is related to insufficient butyric acid in the intestine, or to insufficient butyric-acid-producing microorganisms in the intestine. The present invention further relates to a method for promoting Bifidobacterium lactis HN019 to produce butyric acid, the method comprising using a galactooligosaccharide and lactulose as carbon sources for the cultivation of Bifidobacterium lactis HN019, wherein the weight ratio of the galactooligosaccharide to lactulose is 1:1 to 4:1.
-
公开(公告)号:EP3266310B1
公开(公告)日:2020-06-24
申请号:EP16761039.3
申请日:2016-02-29
申请人: Inner Mongolia Yili Industrial Group Co., Ltd. , Inner Mongolia Dairy Technology Research Institute Co., Ltd.
发明人: FANG, Fang , LI, Ting , ZHAO, Zifu , QI, Bingli , SITU, Wenyou , LI, Wei , LIU, Biao , ZHAO, Hongxia , CHEN, Qingshan
-
公开(公告)号:EP3266310A1
公开(公告)日:2018-01-10
申请号:EP16761039.3
申请日:2016-02-29
申请人: Inner Mongolia Yili Industrial Group Co., Ltd. , Inner Mongolia Dairy Technology Research Institute Co., Ltd.
发明人: FANG, Fang , LI, Ting , ZHAO, Zifu , QI, Bingli , SITU, Wenyou , LI, Wei , LIU, Biao , ZHAO, Hongxia , CHEN, Qingshan
摘要: A nucleotide composition used as a food additive consists of 58-72% CMP, 6-14% AMP, 10-18% UMP and 8-14% GMP, or consists of 58-70% CMP, 7.5-12.5% AMP, 12-16.5% UMP, 10-13% GMP and 0-2.5% IMP. The composition is used to prepare foods, such as an infant food and a dairy product, and achieves the following effects: improving immunostimulation, promoting growth and development, facilitating repair after intestinal injury, promoting the growth of intestinal beneficial microorganisms, and/or any combination thereof.
摘要翻译: 用作食品添加剂的核苷酸组合物由58-72%CMP,6-14%AMP,10-18%UMP和8-14%GMP组成,或者由58-70%CMP,7.5-12.5%AMP,12 -16.5%UMP,10-13%GMP和0-2.5%IMP。 该组合物用于制备婴儿食品和乳制品等食品,并且实现以下效果:改善免疫刺激,促进生长和发育,促进肠损伤后的修复,促进肠内有益微生物的生长和/或任何 它们的组合。
-
-
-
-
-
-
-